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Abstract.  We have studied transport and localization 
of MBP mRNA in oligodendrocytes in culture by 
microinjecting labeled mRNA into living cells and 
analyzing the intracellular distribution of the injected 
RNA by confocal microscopy. Injected mRNA initially 
appears dispersed in the perikaryon.  Within minutes, 
the RNA forms granules which,  in the case of MBP 
mRNA, are transported down the processes to the pe- 
riphery of the cell where the distribution again be- 
comes dispersed. In situ hybridization shows that en- 
dogenous MBP mRNA in oligodendrocytes also 
appears as granules in the perikaryon and processes 
and dispersed in the peripheral membranes.  The gran- 
ules are not released by extraction with non-ionic de- 
tergent,  indicating that they are associated with the 
cytoskeletal matrix.  Three dimensional visualization 
indicates that MBP mRNA granules are often aligned 
in tracks along microtubules traversing the cytoplasm 
and processes. Several distinct patterns of granule 
movement are observed. Granules in the processes un- 
dergo sustained directional movement with a velocity 
of ~,0.2 #m/s.  Granules at branch points undergo os- 
cillatory motion with a mean displacement of 0.1 
#rn/s.  Granules in the periphery of the cell circulate 
randomly with a mean displacement of ,,ol #m/s.  The 
results are discussed in terms of a multi-step pathway 
for transport and localization of MBP mRNA in 
oligodendrocytes. This work represents the first char- 
acterization of intracellular  movement of mRNA in 
living cells, and the first description of the role of 
RNA granules in transport and localization of mRNA 
in cells. 
I 
N eukaryotic cells certain mRNAs are spatially restricted 
to discrete regions within  the cell.  The most general 
example is the localization  of mRNAs for secretory and 
membrane proteins to the rough ER, which is mediated by 
a signal  sequence in the nascent polypeptide chain  (Pfeffer 
and Rothman,  1987).  Other specific examples  of localized 
mRNAs have been demonstrated in very large cells such as 
Xenopus oocytes or Drosophila embryos, in very flat cells 
such as mammalian  cells in tissue culture,  and in cells with 
very polarized morphologies such as neurons and glia of the 
central  nervous system (CNS). 1 
In Xenopus oocytes, the large  size of the cell facilitates 
physical  dissection of the animal  and vegetal poles.  This 
technique has been used to demonstrate that some mRNAs 
(Vgl) are localized to the vegetal pole, while other mRNAs 
(An2)  are localized to the animal  pole (Rebagliati  et al., 
1985). In Drosophila embryos, in situ hybridization has been 
used to demonstrate localization  of certain maternal  tran- 
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scripts during  oogenesis and embryogenesis.  The maternal 
transcript of  the bicoid gene is synthesized in nurse cells, and 
then transported into the oocyte, where it is localized to the 
anterior  pole  (Berleth  et  al.,  1988).  During  oogenesis, 
nanos,  tudor,  and oskar mRNAs are localized to the pos- 
terior  pole  of  the  developing  oocyte  (Ephrussi  et  al., 
1991; Golumbeski et al., 1991; Kim-Ha et al., 1991; Wang 
and  Lehmann,  1991). Later  in  Drosophila  development, 
mRNAs for even-skipped,  fushi tarazu, hairy, and runt are 
localized to the peripheral cytoplasm of the syncitial blasto- 
derm (Ingham et al., 1985; Weir and Kornberg,  1985; Mac- 
donald et al.,  1986; Gergen and Butler,  1988). 
In situ hybridization  has also been used to demonstrate lo- 
calization  of specific mRNAs in cultured mammalian  cells. 
Cells spreading on a substratum localize actin mRNA to the 
lamellipodia  (Singer  et al.,  1989).  Messenger RNAs for 
other cytoskeletal components (tubulin  and vimentin)  are 
also localized to discrete regions of the cell (Lawrence and 
Singer,  1986).  Other mRNAs reported to be localized in 
mammalian  cells are protamine 1 (Braun et al.,  1989) and 
the nicotinic acetyl choline receptor alpha-subunit  (Fontaine 
et al.,  1988). 
In the mammalian  CNS, many cell types send out long 
processes from the cell body, or perikaryon.  In particular 
anatomical sites,  such as the hippocampus, the cell bodies 
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ration of cell body and processes has allowed the use of in 
situ hybridization in CNS sections to study the subcellular 
localization of specific mRNAs  in  neurons.  In  this  way, 
microtubule-associated protein 2 (Bruckenstein et al., 1990; 
Kleiman  et  al.,  1990)  and  the  alpha  subunit  of  cal- 
cium/calmodulin-dependent protein kinase (Burgin et al., 
1990) mRNAs have been shown to be localized to dendrites 
and  excluded  from  axons.  Conversely,  oxytocin  and 
vasopressin mRNAs are localized to axons, but not dendrites 
(Mohr et al.,  1991). 
In  oligodendrocytes,  which  send  out  as  many  as  50 
processes  which wrap around axons and form the myelin 
sheaths in the CNS, myelin basic protein (MBP) mRNA is 
localized to the distal processes. This has been demonstrated 
both by in situ hybridization in intact tissue (Kristensson et 
al., 1986; Verity and Campagnoni, 1988),  and by subcellu- 
lar fractionation of myelin membranes from the brain (Col- 
man et al.,  1982).  MBP mRNA has also been shown to be 
localized to the cell periphery in cultured oligodendrocytes 
by in situ hybridization (Holmes et al., 1988;  Shiota et al., 
1989;  Barbarese,  1991). 
The phenomenon of mRNA localization is clearly estab- 
lished in a variety of systems. However, little is known about 
the mechanism by which localization is  achieved.  Drugs 
which disrupt microtubules and microfilaments perturb the 
establishment  and  the  stabilization,  respectively,  of Vgl 
mRNA localization in the Xenopus oocyte (Yisraeli et al., 
1990). In mammalian cells disruption of actin filaments pre- 
vents actin mRNA localization, while disruption of microtu- 
bules has no effect (Sundell and Singer,  1991). These studies 
suggest that the cytoskeleton is involved in mRNA local- 
ization. 
Most of the previous work on mRNA localization has fo- 
cused on the steady state distribution of total endogenous 
mRNA in fixed cells. This is an equilibrium condition and 
may not be directly relevant to understanding the mechanism 
of RNA localization, which is a dynamic process. Analysis 
of the dynamics and kinetics of mRNA movement in living 
cells is needed to answer fundamental questions about the 
localization mechanism. 
Towards this end, we have studied the intracellular distri- 
bution and movement of exogenous MBP mRNA microin- 
jected into mouse oligodendrocytes growing in primary cul- 
ture. These cells have a characteristic morphology which is 
particularly advantageous for these studies. First, the cell 
body is small and rounded and protrudes from the substrate, 
providing an excellent target for microinjection. Second, the 
processes and peripheral membranes are extremely thin and 
flat, providing excellent optical properties for microscopy. 
This makes it possible to study the three dimensional process 
of intracellular transport in an essentially two dimensional 
system. These morphological peculiarities notwithstanding, 
the oligodendrocyte in culture recapitulates many of the sali- 
ent features of myelin morphogenesis in vivo, and thus pro- 
vides a good experimental system in which to analyze the dy- 
namics of MBP mRNA transport and localization. 
Materials and Methods 
Cell Culture 
Mouse oligodendrocytes were isolated from mixed primary brain cell cul- 
tures after 12-14 d of growth, as described by Barbarese (1991).  The en- 
riched cell population was grown in a mixture of defined medium (Botten- 
stein,  1986)  and conditioned medium from the mouse neuronal cell line 
C1300 in a 2:1 ratio (Giulian et al., 1991). Cells were allowed to differenti- 
ate for 2-3 d after plating before the start of experiments. NIE-115  mouse 
neuroblastoma cells (Kimhi et al.,  1976)  were obtained from Dr.  Leslie 
Loew (University of  Connecticut Health Center, Farmington, CT) and were 
grown in 10% newborn calf serum in DME. Before microinjection, NIE- 
115 cells were plated sparsely on coverslips and treated with differentiation 
medium containing 0.5 % newborn calf serum, 1% DMSO in DME, for 3 d, 
to induce process outgrowth. 
Reagents 
Restriction enzymes and RNA polymerases were obtained from New En- 
gland BioLabs (Beverly, MA), Promega (Madison, WI), and Stratagene (La 
Jolla, CA). RNasin and transcription buffers were from Promega. RNA mo- 
lecular weight markers were obtained from GIBCO BRL (Gaithersburg, 
MD). Diethylpyrocarbonate (DEPC), mineral oil, and ammonium sulfate 
were from Sigma Chem. Co. (St. Louis, MO). 
Recombinant DNA 
Full length cDNA for rat 14 kD MBP was reconstructed from pMBP-1 and 
pMBP-3 (obtained fro  m Dr. A. Roach and described in Roach et al., 1983). 
The reconstructed MBP cDNA was suboloned into pBluescript II (Strata- 
gene) which contains T3 and T7 promoters, pSP64-X~m, containing a full 
length cDNA from Xenopus/aev/s/~-globin, cloned in an SP6 vector, was 
obtained from Dr.  D.  Melton (Harvard,  Cambridge, MA).  Full length 
cDNA for mouse/3-actin, cloned in Bluescript was obtained from Dr. J. 
Pachter (University of Connecticut Health Center, Farmington, CT). 
Transcription and RNA Labeling 
RNA for microinjection was synthesized in vitro from full length cDNA 
clones to generate MBP mRNA and, as controls, globin and actin mRNAs. 
To analyze intracellular distribution and movement, injected RNA was la- 
beled with a reporter moiety to enable visualization. We used two different 
protocols to label RNA. In one protocol, a single fluorophore was cova- 
lently conjugated to the 3' end of the RNA. This provides a stoichiometric 
label on each RNA molecule, which should not affect translation, and which 
can be visualized directly in living cells. However, the fluorescent label is 
potentially subject to photobleaching and photodamage during microscopic 
imaging, which may degrade the image quality and interfere with accurate 
determination  of  intracellular  distribution.  In  the  second  protocol, 
digoxa'genin-labeled  ribonncleotides were incorporated into the body of the 
rnRNA  during  synthesis. The  digoxigenln-labeled RNA  was  visualized 
using anti-digoxigenin antibodies. This provides a greatly amplified signal 
with improved image quality.  However, the digoxigenin moiety may inhibit 
translation of  the RNA, and the cells must be fixed before antibody labeling, 
either of which could affect the intracellular distribution. The use of these 
two different labeling protocols provides important controls for potential 
effects of the image reporter or the imaging procedure on RNA localization. 
Digoxigenin-labeled RNA was prepared by in vitro transcription using 
Promega buffers and protocols. Digoxigehin-11-rUTP was obtained from 
Boehringer Mannheim (Indianapolis, IN) and was used as recommended  by 
the manufacturer. Under these conditions digoxigenin-modified  ribonucleo- 
tides are incorporated every 30-40 residues. Transcription reactions were 
treated with RNase-free DNase and precipitated with potassium acetate and 
ethanol. All samples were dissolved in water and filtered through 0.22 #m 
spin filters (Millipore, Bedford, MA) before microinjection. Transcription 
products were analyzed by agarose gel electrophoresis with RNA markers 
to determine transcript length and to monitor degradation. Only full-length, 
nondegraded samples were used for microinjection. 
Fluorescein-labeled RNA was prepared by a modification of the method 
of Wells and Cantor (1977, 1980).  RNA was transcribed with unsubstituted 
ribonucleotides,  treated  with  RNase-free  DNase,  extracted  with  phe- 
nol:chloroform  and chloroform, and ethanol precipitated. The RNA (5-500 
#g) was dissolved in 58.7 #l DEPC-treated water, and sodium acetate was 
added to a final concentration of  0.1 M, pH 5. One tenth volume of 500 mM 
sodium m-periodate at 37°C was added and the RNA was incubated at 
37°C, for 30 min, in the dark. Ethylene glycol (2/.d) was added, and the 
sample was incubated at room temperature, for 5 rain. The final sample vol- 
ume of 70 #l was gel filtered through a push column (Nuctrap, Stratagane) 
in 0.1 M sodium acetate, pH 5, and extracted with phenol:chloroform and 
chloroform. Fluorescein thiosemicarbizide (FTSC) (Molecular Probes, Eu- 
gene, OR) was added to at least a 25 molar excess over RNA 3' ends and 
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conjugated RNA was extracted  with phenol:chloroform and chloroform, 
and ethanol precipitated to remove most of the unconjugated FTSC.  The 
RNA was gel filtered  to remove any residual FTSC,  extracted  with phe- 
nol:chloroform and chloroform, and ethanol  precipitated. The fluorescein- 
conjugated RNA was analyzed by agarose gel electrophoresis.  No unincor- 
porated FTSC was detected. The coupling efficiency was determined to be 
>90%, using a Spex Fluorolog fluommeter (Spex Industries, Edison, NJ) 
with FITC (Molecular Probes) in 10 mM Tris-HC1, pH 8.0, as a standard. 
Microinjection and Immunocytochemistry 
Before  injection, cells were rinsed with Hepes buffered  Dulbecco's  PBS 
(GIBCO BRL).  Cells were micminjected at room temperature in DUl- 
becco's PBS. RNA concentrations were 0.5-1.0  mg/ml in water.  Cells in- 
jected with digoxiganin-RNA  were incubated at 37°C, for 10 rain, to allow 
time for RNA transport. Cells were fixed with 4% paraformaldehyde  in 5 
mM MgCI2, PBS for 30 rain, washed with PBS, and stored at 4°C. 
Inununocytochemistry followed  manufacturer recommendations for in 
situ hybridization, with the following  changes.  Nonspecific  binding was 
blocked using 0.5%  Boehringer Mannheim Blocking Reagent,  and 10% 
normal goat serum, in 100 mM Tris-HC1,  150 mM sodium chloride, pH 
7.5. Blocking reagent and serum were treated to inactivate nucleases by in- 
cubating (5 mg/mi protein in 100 mM potassium phosphate, pH 7.4) with 
5 mM acetic anhydride.  This was repeated 10 times while maintaining neu- 
tral pH. Proteins were precipitated with ammonium sulfate,  and dialyzed 
against 100 mM Tris-HC1,  150 mM sodium chloride, pH 7.5. Nuclease ac- 
tivity was assayed by incubation with RNA molecular weight markers, fol- 
lowed  by agarose gel  electrophoresis.  Alkaline phosphatase-conjugated 
polyclonal  Fab anti-digoxigenin  was used at 1:1,000 dilution.  Vector Red 
(Vector Lab, Burlingame, CA) was used according to manufacturer sugges- 
tions. Coverslips were dehydrated in 70, 95, and 100% ethanol, Histo-Clear 
(National Diagnostics,  Atlanta, GA), and mounted in Pcrmount (Fisher 
Scientific,  Fair Lawn, NJ). 
Labeling for tubulin was performed on fixed cells after permeabilization 
with detergent.  Rabbit anti-tubulin (Accurate,  Westbury, NY) was used at 
a 1:100 final dilution.  Fluorescein-conjugated goat anti-rabbit  antibody was 
obtained from Organon-Teknica,  and used at 1:100 final dilution. 
Fluorescent RNA was injected into cells on a coverslip  suspended be- 
tween supports in a plastic petri dish, in a Leiden environmental micro- 
chamber (Medical Systems Corp., Greenvale,  NY), on the stage of an up- 
right confocal  microscope. The petri dish was filled with Dulbecco's PBS. 
RNA was injected underneath the coverslip with a flame-bent microinjec- 
tion needle pulled on a Flaming Brown Micropipette Puller (SuRer Instru- 
menUs, San  Rafael,  CA).  Flame-bent needles  were prefilled  with  1  ~tl 
nuclease-free mineral oil before loading with RNA. 
Glass capillaries were treated overnight with 3.5%  (vol/vol)  saturated 
potassium dichromate in concentrated sulfuric acid and washed extensively 
with filtered  DEPC-water to minimize dust and nuclease contamination. 
Cell Extraction 
This protocol is essentially  that of Biegel and Pachter (1991), with minor 
modifications.  The cells were first washed with PBS followed by cytoskele- 
ton (CSK) buffer (0.3 M sucrose,  0.001 M EGTA, 0.01 M Pipes,  pH 6.8, 
0.025 M KCL, 0.005 M MgC12). The cells were then treated with the ex- 
traction buffer (CSK buffer containing 0.2 % Triton X-100) at room temper- 
ature for 30-40 s, and rinsed sequentially with CSK buffer and PBS. The 
remaining "extracted" cells were fixed at room temperature, for 20 rain in 
4 % phosphate-buffered  paraformaldehyde. 
In situ Hybridization 
In situ hybridization was performed according to the protocol of Singer et 
al. (1986) with minor modifications.  The procedure was carried out shortly 
after fixation of the cells with paraformaldehyde  as described above. The 
samples were never stored in alcohol. Digoxigenin-labeled  probe for in sire 
hybridization was prepared by the random oligonucleotide  priming method 
(Feinberg and Vogalstein,  1983) (overnight,  37°C) according to the manu- 
facturer instructions (Boehringer  Mannheim) using dUTP-digoxigenin.  The 
DNA template was a  1.5-kb EcoRI insert fragment representing a partial 
eDNA for rat 14K MBP (Roach et al.,  1983) cloned into a Bluescript II 
vector (Stratagane).  After hybridization, the cells were fixed again, and 
rinsed with PBS, and with 0.2 M Tris-HCl, pH 7.4, 0.1 M glycine  for 10 
rain. The cells were treated with 0.1% NP-40 in PBS for 5 rain, and in- 
cubated with 5% BSA in PBS for 15 min. Immunocytochemistry was per- 
formed using a mouse mAb to digoxigenin  (1:50, Boehringer Mannheim) 
(2 h at room temperature), and fluorescein-  or Texas red-conjugated goat 
anti-mouse antibodies (1:50, Organon Tekuica;  1 h at room temperature). 
The cells were rinsed with PBS and mounted in a  3 % solution of 1,4- 
diazabicyclo[2.2.2.]octane in glycerol. 
Microscopy and Image Processing 
Laser scanning confocal microscopy  was  performed with an MRC-600 
scanning system  (Biorad,  Cambridge,  MA)  mounted on an Axioskope 
(Zeiss, Oberkochen, Germany) equipped with a variety of  infinity-corrected 
high numerical aperture objectives.  Time lapse confocal image collection 
Figure 1.  Digoxigenin-labeled 
exogenous  MBP  mRNA  mi- 
croinjected into oligodendro- 
cytes:  before  and  after  CSK 
extraction.  Digoxigenin- 
labeled MBP mRNA was mi- 
croinjected  into  mouse  oli- 
godendrocytes  as  described 
in  Materials  and  Methods. 
The  ceils  were  rinsed  with 
PBS (A), or treated with CSK 
extraction buffer (B).  Digox- 
igenin-labeled RNA was visu- 
alized by immunocytochemis- 
try and confocal laser scanning 
microscopy.  The  two  cells 
shown  are  representative  of 
several thousand injected ceils 
that  were  examined.  Bar, 
25 ~,m. 
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of endogenous MBP mRNA 
in  oligodendroeytes  before 
and  after  CSK  extraction. 
Oligodendrocytes  grown  in 
culture were rinsed with PBS 
(A), or treated with CSK ex- 
traction  buffer  (B).  Control 
and treated cells were fixed, 
processed for in situ hybrid- 
ization,  and  immunostained 
with  anti-digoxigenin as  de- 
scribed  in  Materials  and 
Methods. Bar, 50/~m. 
was controlled  by a specialized  command  file  written for this purpose. Se- 
ries of  optical sections  for three  dimensional  reconstruction  were  collected 
at 0.5 ~m intervals. This approximates  the optical resolution  in the z axis 
of the microscope  with the objective  used (60×, 1.4 NA). Three dimen- 
sional image data was reconstructed  and visualized using an SGI Iris 340 
VGX graphics supercomputer (Silicon Graphics, Inc., Mountain View, 
CA). Volume  visualization  was performed  using Voxelview  (Vital Images, 
Fairfield, l.A). Isosurface  visualization was performed  using a marching 
cubes algorithm  described  previously  (Morgan et al., 1992). 
Results 
Microinjected MBP mRNA Forms 
IntraceUular Granules 
To analyze the intracellular distribution of exogenous RNA, 
digoxigenin-labeled  MBP  RNA  was  microinjected  into 
mouse oligodendrocytes growing in primary culture (Fig.  1 
A).  The injected RNA  appeared as  small granules which 
were present throughout the cytoplasm and processes, and 
was also found dispersed in the peripheral membranes of the 
cell. The granules were relatively uniform in size (•0.3  #m 
in diameter) and intensity. Most cells contained several hun- 
dred granules but the number varied with the amount of 
RNA injected. Granule formation was not due to the reporter 
molecule incorporated into the RNA  or to the procedure 
used  for  visualization,  because  fluorescein-labeled  MBP 
mRNA  formed similar  granules  when mieroinjected into 
oligodendrocytes and visualized directly in living cells (see 
Fig.  6 A-F). 
Endogenous MBP mRNA in Oligodendrocytes Is Also 
Present in Granules 
The distribution of  endogenous MBP mRNA in oligodendro- 
cytes was examined by high resolution fluorescent in situ hy- 
bridization (Fig. 2 A). MBP mRNA appeared as granules in 
the perikaryon and processes and dispersed in the peripheral 
membranes of the cell. Control experiments where the pri- 
mary antibody was omitted or where shiverer oligodendro- 
cytes (which contain no endogenous MBP because of a dele- 
tion in the MBP gene) were used, showed no granules and 
no dispersed staining in the periphery of the cell (data not 
shown). The number of endogenous MBP mRNA granules 
per cell was generally less than the number of exogenous 
RNA granules in injected cells. However the size and intra- 
cellular distribution of the endogenous RNA granules was 
similar to the exogenous RNA granules. Since the intracellu- 
lar distributions of both endogenous and exogenous MBP 
mRNA in oligodendrocytes are similar, it is likely that this 
accurately  reflects  the  intracellular  distribution  of  MBP 
mRNA in oligodendrocytes. 
Endogenous and Exogenous MBP mRNA Granules 
Are Associated with the Cytoskeletal Matrix 
Both  endogenous  and  exogenous  MBP  mRNA  granules 
sometimes appeared to be aligned in tracks traversing the 
cytoplasm  and  processes,  suggesting  that  they  were  as- 
sociated with the cytoskeleton. To test this possibility, cells 
were extracted with non-ionic detergent which dissolves the 
cell membrane, releasing soluble cytoplasmic components 
and leaving the cytoskeletal matrix intact. Both exogenous 
(Fig. 1 B) and endogenous (Fig. 2 B) MBP mRNA granules 
remained associated with the cytoskeletal matrix after deter- 
gent extraction. In the case of  endogenous MBP mRNA, dis- 
persed RNA in the perikaryon was extracted. In the case of 
exogenous MBP mRNA, the concentration of granules ob- 
scured the dispersed RNA in the perikaryon so it was difficult 
to determine if it was extracted. In both cases the dispersed 
RNA  in  the peripheral membranes  was  extracted.  These 
results indicate that both exogenous and endogenous MBP 
mRNA  granules  are  associated  with  the oligodendrocyte 
cytoskeleton, while dispersed MBP mRNA is not. Cytoskel- 
etal components in oligodendroeytes include microtubules 
and microfilaments but not intermediate filaments (Kachar et 
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are associated with either microtubules or microfilaments. 
Three Dimensional Visualization  of MBP mRNA 
Granules in Oligodendrocytes 
The images in Figs. 1 and 2 represent individual confocal op- 
tical sections through the cell. In each case the focal plane 
was immediately adjacent to the coverslip in order to visual- 
ize the flat processes and peripheral membrane sheets elabo- 
rated by the oligodendrocyte. Because of the thickness of the 
cell body, some of the RNA in the cell was not included in 
the optical section, and does not appear in these images. To 
analyze the three dimensional distribution of microinjected 
labeled MBP mRNA throughout the cell, consecutive optical 
sections through a  single oligodendrocyte were collected, 
reconstructed, and visualized using volume rendering (Fig. 
3 A) or isosurface rendering (Fig. 3 B) techniques. 
An  oligodendrocyte microinjected  with  MBP  mRNA, 
visualized by volume rendering is shown in Fig. 3 A. RNA 
granules were observed throughout the perikaryon and in 
some, but not all, processes. The granules in the perikaryon 
and in the processes appeared to be equivalent in size.  In 
some regions the granules in the processes were aligned in 
tracks. Although not apparent from this image, the nucleus 
was devoid of granules. 
A small subvolume of an oligodendrocyte in which both 
injected MBP mRNA and endogenous tubulin were imaged 
simultaneously, visualized by isosurface rendering is shown 
in Fig. 3 B. In this image the isosurface corresponding to the 
surface of  the process was rendered with partial transparency 
to reveal the surfaces of a microtubule bundle (green) and 
of several RNA granules (red) within the process. The gran- 
ules appeared relatively uniform in size although they dis- 
played a variety of different shapes. Their exact dimensions 
are uncertain because they are close to the resolution limits 
of the microscope and because they may contain other com- 
ponents in addition to the labeled RNA which was visualized. 
The RNA granules appeared to be closely apposed to the 
microtubule bundle in the center of the process. This does 
not necessarily imply direct interaction between RNA and 
microtubules since both the RNA granules and the microtu- 
bule bundle are confined within the small volume of the pro- 
cess.  Nevertheless,  the  RNA  granules  do  appear  to  be 
closely associated with the microtubule bundle and may be 
transported along it. Similar colocalization studies using in 
situ hybridization and immunocytochemistry indicate that 
endogenous MBP mRNA granules are also aligned along 
microtubules in oligodendrocytes (Barbarese, unpublished 
data). 
MBP mRNA Is Differentially  Transported to the 
Periphery in Oligodendrocytes 
The spatial distribution of mRNA within the cell was strik- 
ingly dependent on the type of mRNA injected. In the case 
of MBP mRNA (Figs. 1 A and 4 A), granules were observed 
in the pefikaryon, throughout the length of the processes, 
and  in  the  expanses  of membrane  sheets  elaborated  by 
oligodendrocytes. In addition, MBP mRNA also appeared 
dispersed in the peripheral membrane sheets. In the case of 
globin mRNA (Fig.  4  B),  granules were formed but re- 
mained in the perikaryon, and were not observed in the 
processes and membrane sheets, and globin mRNA never 
appeared dispersed in the membrane sheets. Actin mRNA 
also formed granules which showed a distribution similar to 
that of globin mRNA (data not shown). However,  fluores- 
cein-labeled tRNA and fluorescein-conjugated dextran both 
remained disperse in the perikaryon and did not form gran- 
ules (data not shown). This indicates that granule formation 
is a property of mRNAs in general, but not of other RNAs 
or polysaccharides. Moreover, transport of RNA granules 
down the processes to the periphery of the oligodendrocyte 
is specific for MBP mRNA. 
Formation of mRNA Granules and 
Differential Transport of MBP mRNA Granules to the 
Cell Periphery Is Also Observed in 
Neuroblastoma Cells 
Formation of RNA granules and differential transport of 
MBP mRNA granules to the cell periphery presumably re- 
quires specific factors and transport machinery within the 
cell. To test whether these factors and machinery were pres- 
ent in other cells, MBP and globin mRNAs were injected 
into NIE415 neuroblastoma cells (Fig. 5, A and B). These 
cells extend long neurites but do not elaborate large flat 
membrane sheets like oligodendrocytes. Both MBP mRNA 
and globin mRNA formed granules in NIE415  cells. The 
MBP mRNA granules were transported down the processes 
while globin mRNA granules remained in the perikaryon. 
These results indicate that the factors necessary for forma- 
tion of RNA granules and the cellular machinery necessary 
for differential transport of MBP mRNA granules to the pe- 
riphery of the cell are not specific to oligodendrocytes, but 
are also present in other cells with extended processes. 
Iime Lapse Analysis of MBP mRNA Granule 
Formation in Oligodendrocytes 
To  analyze  the  dynamics  of  RNA  granule  formation, 
fluorescein-labeled  MBP  mRNA  was  microinjected into 
oligodendrocytes, and series of sequential images were col- 
lected at different time points. One example is shown in Fig. 
6, A-E Immediately after injection, fluorescent RNA is dis- 
persed uniformly throughout the perikaryon. Within min- 
utes, the fluorescence in the pcrikaryon begins to appear 
granular. By 7 min after injection, most of the fluorescence 
is present in discrete granules which are visible throughout 
the pcrikaryon and processes. In some regions the granules 
are aligned in tracks which traverse the cytoplasm and con- 
tinue into the processes.  Eventually, fluorescent RNA ac- 
cumulates in a disperse pattern in flat membranous regions 
in the periphery of the cell. In the cell in Fig. 6, disperse 
fluorescence is visible in flat membranes immediately adja- 
cent the perikaryon on the left. This cell is somewhat atypical 
in that granule formation was relatively prolonged. In many 
cells granule formation occurred within the first minute after 
injection at  room temperature  and even more  rapidly at 
37°C. When mRNA was injected into the nucleus, it did not 
form  granules  and  did  not  leave  the  nucleus  (data  not 
shown). These results indicate that MBP mRNA forms gran- 
ules soon after it appears in the cytoplasm and that the gran- 
ules are rapidly transported to the periphery of the cell. 
Ainger et al. Exogenous Myelin Basic Protein mRNA in Oligodendrocytes  435 Figure 3. Three dimensional visualization of digoxigenin-labeled  MBP mRNA microinjected into oligodendrocytes. Digoxigenin-labeled 
MBP mRNA was microinjected into mouse oligodendrocytes and visualized as described in Fig. 1 A. A series of 20 optical sections was 
collected at 0.5-/~m intervals through the cell. The data was reconstructed in three dimensions and displayed using volume rendering (,4). 
Voxels were rendered with an opacity gradient corresponding to the gray scale values except that low level fluorescence corresponding 
to nonspecific staining of the cytoplasm was displayed with slightly enhanced opacity to delineate the cell volume. High level fluorescence 
corresponding to digoxigenin-labeled RNA was displayed with specular highlighting to accentuate the RNA granules. The scale bar in 
A corresponds to 25/~m. B shows isosurface rendering of subvolume containing a portion of an oligodendrocyte process from a cell im- 
munostained simultaneously for both injected MBP mRNA and tubulin. An isosurface boundary of 15 was calculated to delineate the 
volume occupied by low level, nonspecific fluorescence in the oligodendrocyte  process. This isosurface is rendered with partial transparency 
to reveal surfaces within the process. An isosurface boundary of 59 in the green channel was calculated to delineate  the surface ofa micmtu- 
bule bundle contained in the process. This surface is shown in green. An isosurface boundary of 150 in the red channel was calculated 
to delineate the volume occupied by high level fluorescence in RNA granules. This isosurface is shown in red. The different isosurfaces 
are rendered with Gourand shading and specular highlighting. A scale bar is not included in B because of perspective effects within the 
image. 
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MBP  mRNA  and  globin 
mRNA  microinjeeted  into 
oligodendrocytes.  Digoxi- 
genin-labeled  MBP  mRNA 
(A)  and  globin  mRNA  (B) 
were  micminjected  into 
mouse  oligodendrocytes  as 
described  in  Materials  and 
Methods.  The  digoxigenin- 
labeled  RNA was  visualized 
by immunocytochemistry  and 
confocal  laser  scanning  mi- 
croscopy. The two cells shown 
are  representative  of several 
thousand  injected  cells  that 
were examined. Bar, 25 ~m. 
lime Lapse Motion Analysis of  MBP mRNA Granules 
in Oligodendrocytes 
To analyze motion of MBP mRNA granules in oligodendro- 
cytes, series of confocai images were collected at sequential 
time points. In most cells, the majority of granules were rela- 
tively immobile. To identify mobile granules, each series of 
time lapse images was displayed as an animation loop with 
time compression. Granules which exhibited significant dis- 
placements (>1/~m) relative to immobile fiduciary features 
of the cell over the course of the time series were classified 
as mobile. 
Granules  in  oligodendrocyte  processes  displayed  two 
types of motion. Fig. 7 shows a series of images from a por- 
tion of an oligodendrocyte process containing a  single mo- 
bile granule. The granule moved continuously down the pro- 
cess for "o60 s with a sustained velocity of'o0.2 #m/s. When 
it  reached  a  branch  point,  continuous  motion  was  inter- 
rupted,  and the granule underwent  oscillatory motion for 
,o60 s, with a mean displacement of "o0.1 #m/s. By direct 
observation using epifluorescence microscopy, mobile gran- 
ules were observed to move continuously in oligodendrocyte 
processes  for  distances  greater  than  50  /zm,  sometimes 
Figure 5. Digoxigenin-labeled 
MBP  mRNA  and  globin 
mRNA  micminjeeted  into 
NIE-115 neuroblastoma cells. 
Digoxigenin-labeled  MBP 
mRNA (.4) and globin mNRA 
(B)  were  microinjeeted  into 
NIE-115 neuroblastoma  cells 
as described in Materials and 
Methods.  The  digoxigenin- 
labeled  RNA  was  visualized 
by immunocytochemistry  and 
confocal  laser  scanning  mi- 
croscopy. Bar, 50/~m. 
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of RNA granule formation in 
oligodeednmjtes. Fluorescein- 
labeled MBP mRNA was mi- 
cminjected into an oligoden- 
drocyte  as  described  in 
Materials and Methods. A se- 
ries of sequential confocal mi- 
croscopic  images were  col- 
lected at different times after 
injection. (.4) Scanning trans- 
mitted light image of the cell 
before injection, Bar, 10 #m; 
(B) scanning confocal fluores- 
cent image immediately (less 
than 10 s) after injection; (C) 
100 s after injection; (D) 200 s 
after injection; (E) 440 s after 
injection; (F) 660 s after in- 
jection. 
negotiating branch points without interruption. The direc- 
tion of granule movement was always anterograde from the 
perikaryon to the periphery of the cell. Retrograde move- 
ment of granules from the periphery towards the perikaryon 
was never observed. 
Granules in the peripheral membranes displayed a  third 
type of motion. Fig. 8 shows a series of images from a por- 
tion  of oligodendrocyte peripheral  membrane  containing 
several mobile granules. These granules circulate randomly 
and  independently with mean displacements of ,,ol #m/s. 
Cumulative  trajectories  for  three  different  granules  are 
traced in the last panel. Conclusions concerning the mecha- 
nisms of granule mobility will require comprehensive mo- 
tion analysis involving systematic and extensive measure- 
ments on large numbers of granules. 
Discussion 
The work described in this paper was undertaken to eluci- 
date the mechanisms for transport and localization of MBP 
mRNA in oligodendrocytes. The results describe the intra- 
cellular distribution  of exogenous MBP  mRNA  microin- 
jected into oligodendrocytes in culture. Microinjected MBP 
RNA forms intracellular granules in the perikaryon which 
are transported to the processes and peripheral membranes. 
Eventually the  RNA  appears  dispersed  in  the  peripheral 
membranes of the cell. We propose that the various forms 
in which the injected RNA appears represent intermediates 
in a linear multistep transport pathway leading to localization 
of MBP mRNA in the peripheral processes and membranes 
of oligodendrocytes. The pathway is diagrammed in Fig. 9. 
Figure 7. Time lapse analysis 
of RNA granule motion in an 
oligodendrocyte process. Flu- 
orescein-labeled MBP mRNA 
was microinjected into an oli- 
godendrocyte as described in 
Materials and Methods. A se- 
ries of  sequential confocal mi- 
croscopic  images were  col- 
lected  at  10-s intervals.  A 
small portion of an oligoden- 
drocyte process containing a 
mobile granule is shown. The 
position of the granule within 
the process is indicated by an 
arrowhead. Bar, 5  #m. 
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of  RNA granule motion in oli- 
godendrocyte  membranes. 
Fhorescein-labeled  MBP 
mRNA  was  microinjected 
into an oligodendrocyte as de- 
scribed  in  Materials  and 
Methods.  A series of sequen- 
tial confocal microscopic  ~zn- 
ages were collected at 2-s in- 
tervals.  A  small  portion  of 
oligodendrocyte  membrane 
containing  several  mobile 
granules  is shown. The posi- 
tions  of three  separate  gran- 
ules within the membrane are 
indicated  by a,  b,  and  c.  In 
some frames individual gran- 
ules appear elongated or non-spherical. This is because the motion of  the granule is significant in relation to the scan time of  the microscope. 
The sequential positions of the approximate centroids of each of the three granules are shown as cumulative trajectories  in the last frame. 
Bar,  10 #m. 
The proposed pathway  is based on the  assumption that 
each of the observed intermediates is involved with transport 
and localization of MBP mRNA in oligodendrocytes.  It is 
possible that some of the intermediates are involved in other 
aspects of RNA metabolism, such as translation or degrada- 
tion.  These alternatives cannot be evaluated based on the 
data presented here and will not be discussed further. 
The proposed pathway  is  inferred from observations of 
both  exogenous  and  endogenous  MBP  mRNA.  Ideally, 
microinjection should introduce a pulse of exogenous RNA 
into  a  functioning  endogenous  pathway.  The  intracellular 
distribution of exogenous RNA should reflect that of endoge- 
nous RNA. Under the conditions used in this study, the dis- 
tributions of exogenous and endogenous MBP mRNAs in the 
oligodendrocyte  were  qualitatively  similar.  However,  the 
number of exogenous RNA granules  in the  microinjected 
cells (which reflects the amount of exogenous MBP mRNA) 
was generally greater than the number of endogenous RNA 
granules observed by in situ hybridization (which reflects the 
amount of endogenous MBP mRNA). These conditions were 
chosen to ensure that each intermediate in the pathway was 
populated with an amount of exogenous RNA sufficient to 
visualize. 
Immediately after  microinjection,  exogenous  RNA  ap- 
pears dispersed in the perikaryon. A small proportion of en- 
dogenous MBP mRNA in oligodendrocytes also appears dis- 
persed in the perikaryon of intact cells. This represents the 
first intermediate in the proposed pathway.  The dispersed 
Figure 9. Multi-step model for transport and localization of MBP mRNA in oligodendroeytes. The diagram shows a schematic representa- 
tion of an oligodendrocyte. Various subceUular compartments are indicated above the diagram. Postulated sequential intermediates in RNA 
transport and localization are indicated below the diagram.  The diagram is not drawn to scale. The relative sizes of the granules and the 
microtubule  within the cell are expanded for illustrative purposes. 
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indicating that it is not associated with the cytoskeletal ma- 
trix.  This may represent  MBP mRNA recently exported 
from the nucleus, before it associates with the cytoskeleton. 
The dispersed exogenous RNA in the perikaryon is assem- 
bled into RNA granules within minutes of injection. Endog- 
enous  MBP  mRNA  in  oligodendrocytes also  appears  as 
granules in the perikaryon. This represents the second inter- 
mediate in the proposed pathway. The RNA granules in the 
perikaryon  are  mobile.  This  was  determined  by  direct 
epifluorescent microscopic  observation  but  is  not  docu- 
mented  here  because  the  density  of  granules  in  the 
perikaryon makes imaging and motion analysis of individual 
granules difficult. The mechanism for mobility of granules 
in the perikaryon is not known. The RNA granules in the 
perikaryon are not extracted with non-ionic detergent, indi- 
caring that they are associated with the cytoskeletal matrix. 
These results suggest that mRNA is assembled into cytoskel- 
etal-associated granules within minutes of export from the 
nucleus. 
The molecular mechanisms involved in RNA granule for- 
mation are unknown. In the case of  exogenous RNA, granule 
formation occurs in the cytoplasm. RNA injected into the 
nucleus does not form granules and does not exit from the 
nucleus (data not shown). Several different mRNAs (MBP, 
globin, actin) were assembled into granules, but tRNA and 
dextran  were  not,  indicating that granule formation is  a 
general  property  of mRNAs.  The  structural  features  of 
mRNA that mediate granule formation are not known. Based 
on the fluorescence intensity, each granule contains several 
RNA molecules, but it is not known if a single granule con- 
tains  multiple  different  mRNA  species.  Translation  of 
mRNA  is  apparently not required  for granule formation 
since digoxigenin-labeled RNA forms granules but is proba- 
bly not translated because of the large number of substituted 
ribonucleotides. 
This paper represents the first description of mRNA gran- 
ules in cells. Other workers (Taneja et al., 1992), analyzing 
the intracellular distribution of poly A-containing RNA by 
in  situ  hybridization,  have  presented  images  showing  a 
granular distribution of RNA in fibroblasts.  However,  in- 
dividual granules were not resolved. This may be due to the 
thickness of  the fibroblasts compared to oligodendrocytes, or 
because total poly A-containing RNA was visualized rather 
than a single species of mRNA. Also, the granular appear- 
ante of the RNA observed by previous workers may have 
been ascribed to fixation artifact. The RNA granules de- 
scribed here cannot be due to fixation because they are ob- 
served in live, unfixed cells. 
Some MBP mRNA granules in the perikaryon appear to 
be  aligned  in  tracks  extending  from the  nucleus  to  the 
processes, with uniform spacing between individual gran- 
ules. This was observed in both oligodendrocytes and neuro- 
blastoma cells.  The aligned granules are  presumably as- 
sociated  with  cytoskeletal  elements  (microfilaments  or 
microtubules) traversing the cytoplasm. Alignment of MBP 
mRNA granules in tracks may represent an initial sorting 
mechanism that ultimately leads to differential transport and 
localization of MBP mRNA to the periphery of the oligoden- 
drocyte. Non-MBP mRNA (globin and actin) granules were 
not aligned in tracks, indicating that this step may require 
specific cis-acting  dements present in MBP mRNA.  The 
spacing between individual granules in the tracks may reflect 
a rate-limiting step involved in association of MBP mRNA 
granules with the transport machinery. 
MBP mRNA granules in the processes undergo sustained 
anterograde motion with  a  velocity of "o0.2  #m/s.  This 
represents the third intermediate in the proposed pathway. 
The granules are aligned along microtubule bundles in the 
center of the processes. The sustained directional motion of 
mobile granules in processes suggests that this may represent 
a  transport  mechanism to  translocate granules  from the 
pefikaryon to the periphery. The velocity of movement is 
consistent with microtubule-based, kinesin-driven transport 
(Okabe and Hirokawa, 1989;  Vallee and Bloom, 1991). 
At branch points in oligodendrocyte processes, sustained 
motion of MBP mRNA granules is sometimes interrupted 
and the granules undergo oscillatory motion with a mean 
displacement of *0.1 #m/s. This represents the fourth inter- 
mediate in the proposed pathway. Clusters of RNA granules 
at branch points are observed with both endogenous and ex- 
ogenous MBP mRNA and are associated with the cytoskele- 
tal matrix, implying interaction with either microfilaments 
or microtubules. The basis for the oscillatory motion is not 
known.  Mobile  granules  are  observed  distal  to  branch 
points,  indicating that the interruption of motion is tem- 
porary. In many cases granules are found preferentially in 
one branch.  This suggests that oscillatory interruption of 
motion and clustering of granules at branch points reflect a 
sorting  mechanism  to  direct  MBP  mRNA  transport  to 
specific branch processes. If this step is rate limiting it could 
account for the clustering of granules at branch points. This 
mechanism could function in vivo to direct myelin formation 
around specific axons. 
Many MBP mRNA granules are  found in the flattened 
membrane sheets elaborated by oligodendrocytes. Some of 
these granules are relatively immobile, and some undergo 
random circulatory motion with a mean displacement of 1 
#m/s.  These  represent  the  fifth and  sixth  intermediates, 
respectively, in the proposed pathway. The amplitude of dis- 
placement of the mobile granules suggests active movement 
rather than passive diffusion. The mechanism responsible 
for this motion is not known. It seems unlikely that the mo- 
bile granules in this region of the cell are translocating on 
microtubules, because the ordered distribution of microtu- 
bules would not support the random trajectories of granule 
motion that are observed. Since the granules are associated 
with the cytoskeletal matrix, it is possible that granule mo- 
bility  in  this  region  of the  oligodendrocyte is  mediated 
through microfilaments. The functional significance of the 
immobile and mobile MBP mRNA granules in the oligoden- 
drocyte membrane sheets is not known. One hypothesis is 
that the immobile granules represent a stationary intermedi- 
ate, after transport along microtubules has terminated, while 
the mobile granules represent a transitional intermediate be- 
tween microtubule-associated transport and final dispersed 
localization in the membranes. 
A proportion of MBP mRNA appears dispersed in the pe- 
ripheral membrane sheets of oligodendrocytes in culture. 
This  represents  the  seventh intermediate in the proposed 
pathway. There is a lag of several  minutes before microin- 
jected  MBP  mRNA  appears  dispersed  in  the  membrane 
sheets, indicating that this may be the final destination of the 
RNA.  The dispersed MBP mRNA is extracted with non- 
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cytoskeleton. The membrane sheets elaborated by oligoden- 
drocytes  in  culture  correspond  to  the  myelin  membrane 
which is wrapped around  axons to form the myelin sheath 
in vivo.  Localization of MBP mRNA to this region of the 
oligodendrocyte in culture is consistent with localization of 
MBP mRNA to the myelin sheath  in vivo. 
In summary, the results presented in this paper provide the 
basis for a coherent model describing the transport and local- 
ization of MBP mRNA in oligodendrocytes. One unexpected 
feature of this model is the involvement of RNA granules as 
intermediates in the pathway from the perikaryon to the pe- 
ripheral membranes  of the cell.  To our knowledge,  RNA 
granules of this type have not previously been described in 
cells. In addition, the differential intracellular localization of 
microinjected  MBP  mRNA  compared  to  control  mRNA 
provides a means of delineating the cis-acting  elements in 
MBP mRNA that mediate its transport  and localization in 
oligodendrocytes. 
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